ChinaBio会议

ChinaBio®合作论坛已经成为中国首屈一指的生命科学合作会议。2016年的合作论坛吸引了超过900名来自世界各地的决策者,其中近300人来自美国和欧洲,600人来自中国。2017年5月31日至6月1日,第九届合作论坛将首次在珠海举行,一个新兴的华南生命科学中心。珠海将大量的资金和资源投入生命科学产业,包括建立国家的最先进的金湾生物医药园、250000平方米的孵化器、以及研发和生产设施。ChinaBio会议引入EBD集团partneringONE®合作系统,使代表们更加有效地和其他生命科学产业链上的公司进行一对一的会谈。2017年5月31日至6月1日加入我们ChinaBio®合作论坛,和众多来自世界各地的生物技术和制药公司的领导人以及数百名中国的开发技术人员在珠海进行为期两天的交流合作吧!

ChinaBio®合作论坛是中国首要生命科学行业合作论坛。本届论坛将于2015年4月15-16日在上海举行,将吸引到来自全球各地的生物技术和医药界的领先企业及数百位中国的新技术开发商共同参与这成果显著的全球性合作。

ChinaBio®合作论坛2014一共吸引到来自25个国家、400多家企业的850多名参会代表出席,使其成为中国规模最大、以合作为主题的国际性会议。

在线合作系统partneringONE®将再次协助新一届ChinaBio®合作论坛,帮助参会代表们高效地对来自整个生命科学价值链的公司进行鉴别、会见以及建立良好联系。

This exclusive, invitation-only event will attract over 150 senior executives from global pharmaceutical companies, western life science companies and China’s leading biotechs to discuss China's role in shaping the future of the biopharmaceutical industry. This will be an open forum for discussing the issues facing the industry’s rapid growth in China and planning how organizations can best leverage that growth for success. Experts on industry leadership will lead the program with the intent of developing practical techniques and actionable tasks the delegates can put to immediate use in the management of their companies. Our goal is to make the ChinaBio Leadership Retreat a “must attend” annual event for life science executives with interests in China.

ChinaBio®  Partnering Forum is the premier life science partnering event in China. Held on May 7–8, 2014, in Suzhou, the event will attract biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering. ChinaBio® Partnering Forum 2013 had more than 750 delegates from 405 companies and 22 countries, making it the largest partnering conference in China. The 2014 edition promises to be even better with top notch attendance from pharma and biotech companies as well as leading researchers from China's top universities and institutes.

This exclusive, invitation-only event will attract over 150 senior executives from global pharmaceutical companies, western life science companies and China’s leading biotechs to discuss China's role in shaping the future of the biopharmaceutical industry. This will be an open forum for discussing the issues facing the industry’s rapid growth in China and planning how organizations can best leverage that growth for success. Experts on industry leadership will lead the program with the intent of developing practical techniques and actionable tasks the delegates can put to immediate use in the management of their companies. Our goal is to make the ChinaBio Leadership Retreat a “must attend” annual event for life science executives with interests in China.

ChinaBio® LLC and EBD Group will host their fifth ChinaBio® Partnering Forum in China to meet the needs of biotech and pharma companies as well as developers of early stage technology looking for funding and strategic partnerships. The 2012 event brought together 719 attendees from over 432 companies and 23 countries for two days of intense partnering. Participants included most of the major pharma as well as many of China’s biopharmaceutical companies and CROs/CMOs. Join us to meet global pharmas, China biotech companies, VCs and others interested in funding or developing technologies in China.

Under the banner of "personalized medicine," global health care is on the cusp of profound revolutionary changes. A confluence of 21st century innovations - from genomics and proteomics to Big Data analysis and dissemination - makes very real the potential to tailor medical treatments to the specific characteristics of each patient. Foley and ChinaBio invite you to join us for our upcoming executive workshop, which will explore this paradigm shift toward personalized medicine and its global implications for China's life sciences business executives, health care professionals, and academic researchers.
 

This exclusive, invitation-only event will attract over 150 senior executives from global pharmaceutical companies, western life science companies and China’s leading biotechs to discuss China's role in shaping the future of the biopharmaceutical industry. This will be an open forum for discussing the issues facing the industry’s rapid growth in China and planning how organizations can best leverage that growth for success. Experts on industry leadership will lead the program with the intent of developing practical techniques and actionable tasks the delegates can put to immediate use in the management of their companies. Our goal is to make the ChinaBio Leadership Retreat a “must attend” annual event for life science executives with interests in China.

The ChinaBio® Investor Forum in Beijing is a two-day event bringing together investors and early stage life science companies. Up to 20 companies will present their technologies to over 200 attendees, including more than 50 VCs and investors from the US, Europe and China. ChinaBio has held 12 previous Investor Forums in China which have raised over $450M for early stage companies in China, the US and Europe. Don't miss this chance to present your company or see the latest life science technologies in China.

Foley and ChinaBio invite you to join us for our upcoming workshop, “Doing Business in the United States: Practical Steps for Success in the World’s Largest Life Sciences Market.” This seminar is specifically designed for executives and in-house legal counsel for Chinese life sciences companies with some experience doing business in the United States who are interested in learning practical steps to increase their U.S. presence and sales.

ChinaBio® LLC and EBD Group will host their fouth ChinaBio® Partnering Forum in China to meet the needs of biotech and pharma companies as well as developers of early stage technology looking for funding and strategic partnerships. The 2011 event brought together 658 attendees from over 358 companies and 25 countries for two days of intense partnering. Participants included most of the major pharma as well as many of China’s biopharmaceutical companies and CROs/CMOs. Join us to meet global pharmas, China biotech companies, VCs and others interested in funding or developing technologies in China.

The first event of its kind ever to be held in China...

This exclusive, invitation-only event will attract over 150 senior executives from global pharmaceutical companies, western life science companies and China’s leading biotechs to discuss China's role in shaping the future of the biopharmaceutical industry. This will be an open forum for discussing the issues facing the industry’s rapid growth in China and planning how organizations can best leverage that growth for success. Experts on industry leadership will lead the program with the intent of developing practical techniques and actionable tasks the delegates can put to immediate use in the management of their companies. Our goal is to make the ChinaBio Leadership Retreat a “must attend” annual event for life science executives with interests in China.

The fourth annual BioBay Investor Forum is expected to attract more than 250 attendees and 50 VCs to see 20 of China's top life science companies present. The event is organized by ChinaBio® and BioBay, China's fastest growing biotech park. Located less than 30 minutes from Shanghai by high speed train, BioBay has attracted over 200 companies in just four years. The BioBay Investor Forum 2011 will host 20 device, biotechnology, diagnostic, and services companies developing novel technologies to address unmet needs. This year, for the first time, a panel of influential life science investors and executives will judge each company immediately after their presentation. Don’t miss this opportunity to meet with investors active in China or to see novel technologies and investable companies from Suzhou and throughout China.

The ChinaBio® Investor Forum in Jinan is a two-day event bringing together investors and early stage life science companies. Up to 20 companies will present their technologies to over 200 attendees, including more than 50 VCs and investors from the US, Europe and China. ChinaBio has held 10 previous Investor Forums in China which have raised over $450M for early stage companies in China, the US and Europe. Don't miss this chance to present your company or see the latest life science technologies in China.

You are invited to attend the FREE “Developing a Successful Strategy for Entering the U.S. Market” ChinaBio® Executive Workshop as the guest of our host Foley & Lardner LLP. This half-day, complimentary seminar will explore critical aspects of developing an effective going-out strategy and a plan to protect and leverage your life science technology and intellectual capital in the U.S. market. Join other key executives and managers of biotechnology and life science companies interested in learning how to leverage their efforts in China to expand to the U.S. Learn “how to do it” from our speakers who have successfully put their principles into practice in the real world.

Attend for free, thanks to Guangzhou OCS.  Register now!

将在广州举行的本届ChinaBio®创业投资论坛为期一天,是投资商和早期生命科学公司的良好交流平台。20家公司将向来自美国、欧洲和中国的200多位参会代表、50多位VC和投资商路演其技术。ChinaBio的往届诶创业投资论坛已经为中国早期生命科学公司融资逾3.5亿美金。抓住本次会议良机,进行公司路演、了解中国最新的生命科学技术!

China Forum 2010 will be a half day event, bringing together China-based life science executives with their counterparts from Europe and the rest of the world. The event will provide insights into recent developments of the rapidly changing life science industry in China. Executives from China and the West will discuss partnering opportunities and attendees will gain essential knowledge on how to step into new marketplaces. In an interactive setting, attendees from Western countries will hear what it takes to succeed in China, and Chinese executives will learn how to leverage their business by partnering with European and American companies. China Forum will precede EBD Group’s international partnering conference, BIO-Europe 2010.

由ChinaBio®和BioBay共同主办的第三届年度BioBay创业投资论坛将于苏州举行,为期两天。多方投资商和来自中国各地的早期生命科学公司将汇聚苏州纳米科技园(BioBay) - 中国成长最快的生命科学园之一。20家公司将向250多位参会者及50多位VC和投资商进行公司路演。这将是ChinaBio® LLC在中国主办的第九届创业投资论坛。往届活动已经为中国的早期公司融资逾3.5亿美金。

The ChinaBio® Investor Forum returns to Shanghai for the first time since 2008. 20 early stage biotechnology, diagnostics, medical device and services companies from throughout China will be presenting. Attendees will have the opportunity to screen these companies in a rapid two-day forum that also offers educational sessions on the state of the biotechnology industry and VC investment in China from over 25 experts.

The finalists of the SEED Business Plan Competition will present to a judges panel made up of venture capitalists, scientists, industry executives and others. There will also be industry experts speaking on the industry and entrepreneurship. The event will end with the award ceremony, where a grand prize of RMB 300,000 will be announced. Three participants will also be awarded a SEED Winners Tour, an all-expense paid trip to the US, sponsored by BioCentury.

Up to fifteen semi-finalists will be selected from previously submitted business plans. These finalists will be invited to attend the SEED Finalists Coaching Day to be held on March 2, 2010 in Shanghai where they will receive hands-on coaching. Presentations and additional coaching will be provided by the organizers and others during this one-day event. Attendees will include semi-finalists and other entrants, judges/coaches, and anyone interested in entrepreneurship and China’s life science industry.

This half-day training/coaching workshop will include presentations from the organizers and others to potential submitting companies and academicians, as well as others interested in China’s rapidly growing life science industry.

This one-day training/coaching workshop will include presentations from the organizers and others to potential submitting companies and academicians, as well as others interested in China’s rapidly growing life science industry.

This one-day training/coaching workshop will include presentations from the organizers and others to potential submitting companies and academicians, as well as others interested in China’s rapidly growing life science industry.

The Second Annual BioBay Investor Forum in Suzhou, presented by ChinaBio®, is a two-day event bringing together investors and early stage life science companies at BioBay, the fastest growing life science park in China.  20 companies will be presenting their technologies to over 200 attendees, including more than 50 VCs and investors.  This will be the sixth Investor Forum and eight event ChinaBio® Accelerator has organized in China.  These events have raised over $100M for early stage companies in China.

ChinaBio® LLC and EBD Group will host the first ChinaBio® Partnering Forum in Shanghai to meet the needs of biotech and pharma companies as well as developers of early stage technology looking for funding and strategic partnerships. This event will bring together over 500 attendees from around world for two days of one-to-one partnering meetings using EBD Group’s acclaimed partneringONE™ online system. There will also be experts speaking on China’s life science industry, over 40 presentations on technologies from China, and posters from China’s top universities and institutes. Join us to meet global pharmas, China biotech companies, VCs and others interested in funding or developing technologies in China.

 

The ChinaBio® Investor Forum, hosted by Hong Kong Hong Kong Science and Technology Parks, exceeded all expectations for this first time event in Hong Kong. Over 220 attendees were present to see early stage biotechnology, diagnostics, medical device and services companies from the Pearl River Delta. There were also educational sessions on the state of the biotechnology industry and VC investment in China and Hong Kong from over 25 experts. Companies winning the Most Promising Company awards were Sinoasia (Guangzhou) and GeneHarbor (Hong Kong).
 

The first ChinaBio® Investor Forum held in Beijing was a huge success. It attracted nearly 200 attendees, 50 VCs and 20 presenting companies from throughout China. The winners of the Most Promising Company Awards were Protelight/BioAMPs and Fountain Medical.  Our Investor Forums have become well known as "the place" to find early stage life science investment and partnering opportunities in China. Our previous presenting companies have raised over $60M from VCs and big pharma who have attended our events.

The BioBay Investor Forum 2008 in Suzhou hosted sixteen early stage biotechnology, diagnostics and services companies developing novel technologies and addressing unmet needs. Attendees had the opportunity to screen these companies in a rapid one and one-half day forum that also featured educational sessions on operating a global biotech company in China, and how to attract venture captial. VCs and industry executives and analysts also addressed the state of the biotechnology industry and VC investment in China.

This year's ChinaBio Investor Forum in Shanghai was a huge success.  Over 270 attendees, including nearly 80 venture capitalists, saw 21 early stage companies present their business plans.  There were also 24 VCs and industry executives speaking on the state of VC investment in China life sciences. The winners of the Most Promising Company Awards were  Beyond Diagnostics and Allist Pharmaceuticals. 

The ChinaBio® Investor Forum 2007 was our first Investor Forum held in China.  There were over 150 attendees, including 50 venture capitalists, who saw 15 early stage companies present their business plans.  There were also over 20 VCs and industry executives speaking on the state of VC investment in China life sciences. The winners of the Most Promising Company Awards were  ChiralQuest and PegBio, both of which have raised VC funding as a result of presenting at the event.. 

GF Securities is hosting its first GF Securities Life Sciences Investment Conference (GFIC2017) in Guangzhou on July 3-4, 2017.  This premier event is the only investment event held in conjunction with the 10th China Biosciences Annual Conference, which features Alibaba founder Jack Ma, Nobel Prize Winners Dr. Richard Roberts and Dr. Peter Charles Doherty, as well as Dr. Xiaodong Wang, BeiGene co-founder and AAS and CAS Fellow, as speakers.  GFIC2017 attendees will have the chance to interact with nearly 100 listed Chinese life science companies, with a total market cap exceeding 900 billion USD.  These companies have a strong desire to invest in or acquire China and US/EU-based companies, in-license novel technologies, or partner to bring products to China.  There will also be a road show of invited companies presenting their novel technologies and products.  Industry and regulatory experts including Roger Luo, GM of Gilead China, and Dr. Richard Myers, Hudsonalpha Institute President and former Chair of Department of Genetics, Stanford University School of Medicine, will present updates on the rapid evolution of the industry, including cross-border investment and the China market. 
 
Please join us for this unique opportunity to meet with leaders of the life science industry in China, as well as up-coming entrepreneurs and active investors at the first GF Securities Life Sciences Investment Conference in Guangzhou on July 3-4, 2017.
 
Hosted by: GF Securities
Co-organized by: GF XINDE Investment Management, Bay City Capital and ChinaBio® Group